CABG Medical suspends clinical trial for synthetic heart bypass device
This article was originally published in Clinica
Executive Summary
CABG Medical has suspended enrolment in an international clinical trial of it synthetic heart bypass graft, after two of the grafts became occluded before the patient's discharge from hospital.